Starling Oncology (STLNW) Capital Expenditures Growth (1y) (2022 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) Capital Expenditures Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.21 Bn | 1.16 Bn | 40.24% |
| 2 | RadNet | 5.50 Bn | 4.77 Bn | 88.08 Mn | -78.17% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | - |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | -37.90% |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | 36.75% |
| 6 | Pediatrix Medical | 2.15 Bn | 1.75 Bn | - | 127.85% |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn | 18.03% |
| 8 | Surgery Partners | 1.85 Bn | 1.63 Bn | 622.10 Mn | -6.84% |
| 9 | U S Physical Therapy | 1.18 Bn | 1.15 Bn | 41.94 Mn | 65.00% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | -24.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -24.83% |
| Mar 31, 2026 | 217.68% |
| Dec 31, 2025 | -39.60% |
| Sep 30, 2025 | 250.25% |
| Jun 30, 2025 | -33.84% |
| Mar 31, 2025 | -46.23% |
| Dec 31, 2024 | 103.83% |
| Sep 30, 2024 | -143.23% |
| Jun 30, 2024 | 94.88% |
| Mar 31, 2024 | -66.83% |
| Dec 31, 2023 | -56.84% |
| Sep 30, 2023 | -21.85% |
| Jun 30, 2023 | -30.18% |
| Mar 31, 2023 | 83.53% |
| Dec 31, 2022 | 129.05% |
| Sep 30, 2022 | 25.26% |
| Jun 30, 2022 | 229.73% |
| Mar 31, 2022 | 61.87% |